<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20260526069540N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-07-20</date_registration>
      <primary_sponsor>Allameh Tabataba'i University</primary_sponsor>
      <public_title>Investigation of the Effect of Respiratory Fatigue on Gait Pattern</public_title>
      <acronym></acronym>
      <scientific_title>Comparing the effect of respiratory muscle fatigue on the gait pattern of active and inactive older adults</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-07-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/90466</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Aging.</hc_freetext>
      <i_freetext>Intervention 1: Intervention Group 1 (Active Older Adults):The intervention in this study consists of the acute induction of respiratory muscle fatigue through inspiratory muscle resistance training using the PowerBreathe inspiratory muscle trainer. This device is an adjustable mechanical instrument that provides resistance during inspiration, allowing the training intensity to be individualized based on each participant's maximal inspiratory pressure (PImax).Prior to the intervention, each participant's maximal inspiratory pressure (PImax) is measured using a handheld mouth pressure manometer. Participants perform three maximal inspiratory efforts with one-minute rest intervals between attempts, and the highest recorded value is considered the baseline PImax.Following the determination of PImax, the resistance of the inspiratory muscle trainer is set at 60% of the participant's baseline PImax. Participants perform repeated forceful inspiratory breaths through the device while seated in a standardized upright position. The intervention is conducted as a single acute laboratory session and consists of one bout of inspiratory muscle resistance exercise performed until the criterion for respiratory muscle fatigue is reached.The protocol continues until the participant is unable to generate at least 90% of the baseline PImax in three consecutive maximal inspiratory efforts. This criterion is considered indicative of functional respiratory muscle fatigue. Once fatigue is confirmed, the participant immediately proceeds to the post-intervention walking assessment, during which spatiotemporal gait parameters are reassessed.The intervention is performed only once and is designed solely to induce acute, transient respiratory muscle fatigue. Therefore, it does not involve a multi-session training program or any form of long-term respiratory muscle training. Intervention 2: Intervention Group 2 (Inactive Older Adults):The intervention in this study consists of the acute induction of respiratory muscle fatigue through inspiratory muscle resistance training using the PowerBreathe inspiratory muscle trainer. This device is an adjustable mechanical instrument that provides resistance during inspiration, allowing the training intensity to be individualized based on each participant's maximal inspiratory pressure (PImax).Prior to the intervention, each participant's maximal inspiratory pressure (PImax) is measured using a handheld mouth pressure manometer. Participants perform three maximal inspiratory efforts with one-minute rest intervals between attempts, and the highest recorded value is considered the baseline PImax.Following the determination of PImax, the resistance of the inspiratory muscle trainer is set at 60% of the participant's baseline PImax. Participants perform repeated forceful inspiratory breaths through the device while seated in a standardized upright position. The intervention is conducted as a single acute laboratory session and consists of one bout of inspiratory muscle resistance exercise performed until the criterion for respiratory muscle fatigue is reached.The protocol continues until the participant is unable to generate at least 90% of the baseline PImax in three consecutive maximal inspiratory efforts. This criterion is considered indicative of functional respiratory muscle fatigue. Once fatigue is confirmed, the participant immediately proceeds to the post-intervention walking assessment, during which spatiotemporal gait parameters are reassessed.The intervention is performed only once and is designed solely to induce acute, transient respiratory muscle fatigue. Therefore, it does not involve a multi-session training program or any form of long-term respiratory muscle training.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is Due to the lack of plans for sharing individual participant data, no additional information is available.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Reza Norouzi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 14, Ahmad Abbasi Alley, Moftazi Street, Navab Highway, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1331684969</zip>
        <telephone>+98 916 927 3651</telephone>
        <email>reznrz148@gmail.com</email>
        <affiliation>Allameh Tabataba'i University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Reza Norouzi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No 81، Acadia Medical Equipment Passage Navab Highway، Tehran، Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1331684969</zip>
        <telephone>+98 916 927 3651</telephone>
        <email>reznrz148@gmail.com</email>
        <affiliation>Allameh Tabataba'i University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Being in the 65–70 age range
Living in the city of Tehran
Having the ability to carry out daily activities and participate in assessments
Completing the Physical activity questionnaire to determine the individual's level of physical activity
Having a body mass index (BMI) within the normal range</inclusion_criteria>
      <agemin>65 years</agemin>
      <agemax>70 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention Group 1 (Active Older Adults):The intervention in this study consists of the acute induction of respiratory muscle fatigue through inspiratory muscle resistance training using the PowerBreathe inspiratory muscle trainer. This device is an adjustable mechanical instrument that provides resistance during inspiration, allowing the training intensity to be individualized based on each participant's maximal inspiratory pressure (PImax).Prior to the intervention, each participant's maximal inspiratory pressure (PImax) is measured using a handheld mouth pressure manometer. Participants perform three maximal inspiratory efforts with one-minute rest intervals between attempts, and the highest recorded value is considered the baseline PImax.Following the determination of PImax, the resistance of the inspiratory muscle trainer is set at 60% of the participant's baseline PImax. Participants perform repeated forceful inspiratory breaths through the device while seated in a standardized upright position. The intervention is conducted as a single acute laboratory session and consists of one bout of inspiratory muscle resistance exercise performed until the criterion for respiratory muscle fatigue is reached.The protocol continues until the participant is unable to generate at least 90% of the baseline PImax in three consecutive maximal inspiratory efforts. This criterion is considered indicative of functional respiratory muscle fatigue. Once fatigue is confirmed, the participant immediately proceeds to the post-intervention walking assessment, during which spatiotemporal gait parameters are reassessed.The intervention is performed only once and is designed solely to induce acute, transient respiratory muscle fatigue. Therefore, it does not involve a multi-session training program or any form of long-term respiratory muscle training.</i_keyword>
      <i_keyword>Intervention Group 2 (Inactive Older Adults):The intervention in this study consists of the acute induction of respiratory muscle fatigue through inspiratory muscle resistance training using the PowerBreathe inspiratory muscle trainer. This device is an adjustable mechanical instrument that provides resistance during inspiration, allowing the training intensity to be individualized based on each participant's maximal inspiratory pressure (PImax).Prior to the intervention, each participant's maximal inspiratory pressure (PImax) is measured using a handheld mouth pressure manometer. Participants perform three maximal inspiratory efforts with one-minute rest intervals between attempts, and the highest recorded value is considered the baseline PImax.Following the determination of PImax, the resistance of the inspiratory muscle trainer is set at 60% of the participant's baseline PImax. Participants perform repeated forceful inspiratory breaths through the device while seated in a standardized upright position. The intervention is conducted as a single acute laboratory session and consists of one bout of inspiratory muscle resistance exercise performed until the criterion for respiratory muscle fatigue is reached.The protocol continues until the participant is unable to generate at least 90% of the baseline PImax in three consecutive maximal inspiratory efforts. This criterion is considered indicative of functional respiratory muscle fatigue. Once fatigue is confirmed, the participant immediately proceeds to the post-intervention walking assessment, during which spatiotemporal gait parameters are reassessed.The intervention is performed only once and is designed solely to induce acute, transient respiratory muscle fatigue. Therefore, it does not involve a multi-session training program or any form of long-term respiratory muscle training.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Step length. Timepoint: Before the intervention, immediately after the intervention. Method of measurement: ZEBRIS gait analysis system.</prim_outcome>
      <prim_outcome>Step width. Timepoint: Before the intervention, immediately after the intervention. Method of measurement: ZEBRIS gait analysis system.</prim_outcome>
      <prim_outcome>Double support phase. Timepoint: Before the intervention, immediately after the intervention. Method of measurement: ZEBRIS gait analysis system.</prim_outcome>
      <prim_outcome>Single support phase of the right and left legs. Timepoint: Before the intervention, immediately after the intervention. Method of measurement: ZEBRIS gait analysis system.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Allameh Tabataba'i University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-04-27</approval_date>
        <contact_name>Ethics committee of َAllameh Tabataba'i University</contact_name>
        <contact_address>Central Campus, Allameh Tabataba’i University, Olympic Village, Olympic Village Square, Tehran. tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
